Variants of CARD15, TNFA and PTPN22 and susceptibility to Crohn's disease in the Czech population: High frequency of the CARD15 1007fs

Tissue Antigens

Volumn 71, Issue 6, 2008, Pages 538-547

  Hradsky, O ^a   Lenicek, M ^b   Dusatkova, P ^a   Bronsky, J ^a   Nevoral, J ^a   Valtrova, V ^a   Kotalova, R ^a   Szitanyi, P ^a   Petro, R ^c   Starzykova, V ^b   Bortlik, M ^b   Vitek, L ^b   Lukas, M ^b   Cinek, O ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c University Hospital Motol ^*  (Czech Republic)

Author keywords

Age at onset; Clinical characteristics; Genetic association; TNFA

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE NONRECEPTOR 22; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CARD15 GENE; CASE CONTROL STUDY; CONTROLLED STUDY; CROHN DISEASE; CZECH REPUBLIC; FEMALE; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; PTPN22 GENE; TNFA GENE;

ADOLESCENT; ADULT; AGE OF ONSET; CASE-CONTROL STUDIES; CHILD; CROHN DISEASE; CZECH REPUBLIC; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; NOD2 SIGNALING ADAPTOR PROTEIN; PHENOTYPE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; TUMOR NECROSIS FACTOR-ALPHA;

EID: 43849100606     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2008.01047.x     Document Type: Article

References (58)

1. The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007 : 447 : 661 78.
2. Libioulle C, Louis E, Hansoul S et al. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet 2007 : 3 : e58.
3. Gaya DR, Russell RK, Nimmo ER, Satsangi J. New genes in inflammatory bowel disease: lessons for complex diseases? Lancet 2006 : 367 : 1271 84.
4. Hugot JP, Laurent-Puig P, Gower-Rousseau C et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996 : 379 : 821 3.
5. Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001 : 411 : 599 603.
6. Ferraris A, Knafelz D, Torres B, Fortina P, Castro M, Dallapiccola B. Analysis of CARD15 gene variants in Italian pediatric patients with inflammatory bowel diseases. J Pediatr 2005 : 147 : 272 3.
7. Sun L, Roesler J, Rosen-Wolff A et al. CARD15 genotype and phenotype analysis in 55 pediatric patients with Crohn disease from Saxony, Germany. J Pediatr Gastroenterol Nutr 2003 : 37 : 492 7.
8. Hampe J, Grebe J, Nikolaus S et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Lancet 2002 : 359 : 1661 5.
9. Mendoza JL, Murillo LS, Fernandez L et al. Prevalence of mutations of the NOD2/CARD15 gene and relation to phenotype in Spanish patients with Crohn disease. Scand J Gastroenterol 2003 : 38 : 1235 40.
10. Vermeire S, Wild G, Kocher K et al. CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure. Am J Hum Genet 2002 : 71 : 74 83.
11. Ahmad T, Armuzzi A, Bunce M et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 2002 : 122 : 854 66.
12. Lesage S, Zouali H, Cezard JP et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002 : 70 : 845 57.
13. Seiderer J, Brand S, Herrmann KA et al. Predictive value of the CARD15 variant 1007fs for the diagnosis of intestinal stenoses and the need for surgery in Crohn's disease in clinical practice: results of a prospective study. Inflamm Bowel Dis 2006 : 12 : 1114 21.
14. Abreu MT, Taylor KD, Lin YC et al. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology 2002 : 123 : 679 88.
15. Strober W, Murray PJ, Kitani A, Watanabe T. Signalling pathways and molecular interactions of NOD1 and NOD2. Nat Rev Immunol 2006 : 6 : 9 20.
16. van Heel DA, Fisher SA, Kirby A, Daly MJ, Rioux JD, Lewis CM. Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Hum Mol Genet 2004 : 13 : 763 70.
17. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 1997 : 94 : 3195 9.
18. Lee YH, Rho YH, Choi SJ et al. The PTPN22 C1858T functional polymorphism and autoimmune diseases - a meta-analysis. Rheumatology (Oxford) 2007 : 46 : 49 56.
19. Martin MC, Oliver J, Urcelay E et al. The functional genetic variation in the PTPN22 gene has a negligible effect on the susceptibility to develop inflammatory bowel disease. Tissue Antigens 2005 : 66 : 314 7.
20. Prescott NJ, Fisher SA, Onnie C et al. A general autoimmunity gene (PTPN22) is not associated with inflammatory bowel disease in a British population. Tissue Antigens 2005 : 66 : 318 20.
21. van Oene M, Wintle RF, Liu X et al. Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn's disease, in Canadian populations. Arthritis Rheum 2005 : 52 : 1993 8.
22. Wagenleiter SE, Klein W, Griga T, Schmiegel W, Epplen JT, Jagiello P. A case-control study of tyrosine phosphatase (PTPN22) confirms the lack of association with Crohn's disease. Int J Immunogenet 2005 : 32 : 323 4.
23. IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis - the Porto criteria. J Pediatr Gastroenterol Nutr 2005 : 41 : 1 7.
24. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989 : 170 (Suppl 16 9 discussion.
25. Walter SD. The estimation and interpretation of attributable risk in health research. Biometrics 1976 : 32 : 829 49.
26. Silverberg MS, Satsangi J, Ahmad T et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005 : 19 (Suppl A 5 36.
27. Economou M, Trikalinos TA, Loizou KT, Tsianos EV, Ioannidis JP. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol 2004 : 99 : 2393 404.
28. Cuthbert AP, Fisher SA, Mirza MM et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002 : 122 : 867 74.
29. Hugot JP, Zaccaria I, Cavanaugh J et al. Prevalence of CARD15/NOD2 mutations in Caucasian healthy people. Am J Gastroenterol 2007 : 102 : 1259 67.
30. Medici V, Mascheretti S, Croucher PJ et al. Extreme heterogeneity in CARD15 and DLG5 Crohn disease-associated polymorphisms between German and Norwegian populations. Eur J Hum Genet 2006 : 14 : 459 68.
31. Helio T, Halme L, Lappalainen M et al. CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease. Gut 2003 : 52 : 558 62.
32. Arnott ID, Nimmo ER, Drummond HE et al. NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe? Genes Immun 2004 : 5 : 417 25.
33. Economou M, Filis G, Tsianou Z et al. Crohn's disease incidence evolution in North-western Greece is not associated with alteration of NOD2/CARD15 variants. World J Gastroenterol 2007 : 13 : 5116 20.
34. Giachino D, van Duist MM, Regazzoni S et al. Analysis of the CARD15 variants R702W, G908R and L1007fs in Italian IBD patients. Eur J Hum Genet 2004 : 12 : 206 12.
35. Annese V, Palmieri O, Latiano A et al. Frequency of NOD2/CARD15 variants in both sporadic and familial cases of Crohn's disease across Italy. An Italian Group for Inflammatory Bowel Disease Study. Dig Liver Dis 2004 : 36 : 121 4.
36. Nunez C, Barreiro M, Dominguez-Munoz JE, Lorenzo A, Zapata C, Pena AS. CARD15 mutations in patients with Crohn's disease in a homogeneous Spanish population. Am J Gastroenterol 2004 : 99 : 450 6.
37. De Diego C, Alcantara M, Valle J et al. Frequency of CARD15 polymorphisms in patients with Crohn's disease from Toledo, Spain: genotype-phenotype correlation. Genet Test 2006 : 10 : 178 85.
38. Ferreira AC, Almeida S, Tavares M et al. NOD2/CARD15 and TNFA, but not IL1B and IL1RN, are associated with Crohn's disease. Inflamm Bowel Dis 2005 : 11 : 331 60.
39. Buning C, Genschel J, Buhner S et al. Mutations in the NOD2/CARD15 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation. Aliment Pharmacol Ther 2004 : 19 : 1073 8.
40. Lakatos PL, Lakatos L, Szalay F et al. Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: phenotype-genotype correlations. World J Gastroenterol 2005 : 11 : 1489 95.
41. Buning C, Molnar T, Nagy F et al. NOD2/CARD15 gene polymorphism in patients with inflammatory bowel disease: is Hungary different? World J Gastroenterol 2005 : 11 : 407 11.
42. Ronningen KS, Keiding N, Green A. Correlations between the incidence of childhood-onset type I diabetes in Europe and HLA genotypes. Diabetologia 2001 : 44 (Suppl 3 B51 9.
43. Newman B, Silverberg MS, Gu X et al. CARD15 and HLA DRB1 alleles influence susceptibility and disease localization in Crohn's disease. Am J Gastroenterol 2004 : 99 : 306 15.
44. Cukovic-Cavka S, Vermeire S, Hrstic I et al. NOD2/CARD15 mutations in Croatian patients with Crohn's disease: prevalence and genotype-phenotype relationship. Eur J Gastroenterol Hepatol 2006 : 18 : 895 9.
45. Tomer G, Ceballos C, Concepcion E, Benkov KJ. NOD2/CARD15 variants are associated with lower weight at diagnosis in children with Crohn's disease. Am J Gastroenterol 2003 : 98 : 2479 84.
46. Leshinsky-Silver E, Karban A, Buzhakor E et al. Is age of onset of Crohn's disease governed by mutations in NOD2/caspase recruitment domains 15 and Toll-like receptor 4? Evaluation of a pediatric cohort. Pediatr Res 2005 : 58 : 499 504.
47. Weiss B, Shamir R, Bujanover Y et al. NOD2/CARD15 mutation analysis and genotype-phenotype correlation in Jewish pediatric patients compared with adults with Crohn's disease. J Pediatr 2004 : 145 : 208 12.
48. Idestrom M, Rubio C, Granath F, Finkel Y, Hugot JP. CARD15 mutations are rare in Swedish pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2005 : 40 : 456 60.
49. Wine E, Reif SS, Leshinsky-Silver E et al. Pediatric Crohn's disease and growth retardation: the role of genotype, phenotype, and disease severity. Pediatrics 2004 : 114 : 1281 6.
50. Russell RK, Drummond HE, Nimmo EE et al. Genotype-phenotype analysis in childhood-onset Crohn's disease: NOD2/CARD15 variants consistently predict phenotypic characteristics of severe disease. Inflamm Bowel Dis 2005 : 11 : 955 64.
51. de Ridder L, Weersma RK, Dijkstra G et al. Genetic susceptibility has a more important role in pediatric-onset Crohn's disease than in adult-onset Crohn's disease. Inflamm Bowel Dis 2007 : 13 : 1083 92.
52. Brant SR, Picco MF, Achkar JP et al. Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes. Inflamm Bowel Dis 2003 : 9 : 281 9.
53. Lappalainen M, Paavola-Sakki P, Halme L et al. Novel CARD15/NOD2 mutations in Finnish patients with Crohn's disease and their relation to phenotypic variation in vitro and in vivo. Inflamm Bowel Dis 2007 : 14 : 176 85.
54. Vermeire S, van Assche G, Rutgeerts P. Review article: altering the natural history of Crohn's disease - evidence for and against current therapies. Aliment Pharmacol Ther 2007 : 25 : 3 12.
55. Stokkers PC, Reitsma PH, Tytgat GN, van Deventer SJ. HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis. Gut 1999 : 45 : 395 401.
56. Levine A, Karban A, Eliakim R et al. A polymorphism in the TNF-alpha promoter gene is associated with pediatric onset and colonic location of Crohn's disease. Am J Gastroenterol 2005 : 100 : 407 13.
57. Sykora J, Subrt I, Didek P et al. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease. J Pediatr Gastroenterol Nutr 2006 : 42 : 479 87.
58. Cucchiara S, Latiano A, Palmieri O et al. Polymorphisms of tumor necrosis factor-alpha but not MDR1 influence response to medical therapy in pediatric-onset inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2007 : 44 : 171 9.